Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Dong-A conducts phase II study with DA-8010 in overactive bladder

July 31, 2018

Mitobridge describes new ACMSD inhibitors

July 26, 2018

SSAO inhibitors identified at Ube Industries

July 25, 2018

Active substance in ROSgard protects kidney tissue in preclinical acute kidney injury study

July 24, 2018

Reata reports promising phase II data from bardoxolone trials in chronic kidney disease

July 24, 2018

Bridge Medicines and Memorial Sloan Kettering partner on platform to deliver drugs to kidneys

July 24, 2018

Kissei Pharmaceutical synthesizes new TRPM8 antagonists

July 19, 2018

Novel CD-1db/db mouse model of type 2 diabetes with progressive kidney fibrosis

July 18, 2018

Phase III CREDENCE trial of Invokana stopped early due to promising outcomes

July 17, 2018

Novel surgically induced rat model of diabetic nephropathy

July 13, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...